Zobrazeno 1 - 10
of 240
pro vyhledávání: '"Otieno MA"'
Publikováno v:
BMJ (Clinical research ed.) [BMJ] 2024 Apr 15; Vol. 385, pp. q853. Date of Electronic Publication: 2024 Apr 15.
Autor:
Guinto RR; Planetary and Global Health Program, St. Luke's Medical Center College of Medicine-William H. Quasha Memorial, Quezon City, Philippines.; Sunway Centre for Planetary Health, Sunway University, Selangor, Malaysia., Deivanayagam TA; Institute for Global Health, University College London, London, United Kingdom.; Lancaster Medical School, Faculty of Health and Medicine, Lancaster University, Lancaster, United Kingdom., Chuji PT; Faculty of Human, Social and Political Sciences, University of Cambridge, Cambridge, United Kingdom., Hossan A; Department of Sociology, Colorado State University, Fort Collins, Colorado, United States of America.; Interdisciplinary Training, Education and Research in Food-Energy-Water Systems, Colorado State University, Fort Collins, Colorado, United States of America., Jensen A; Department of Civil and Environmental Engineering, Stanford University, California, United States of America., Jung L; German Alliance on Climate Change and Health, Germany.; Leipzig University Hospital, Division of Infectious Diseases and Tropical Medicine, Leipzig, Germany., Njuguna E; Fridays for Future MAPA., Osborne R; School of Clinical Medicine, University of Cambridge, Cambridge, United Kingdom.; The People's Health Movement, Global and United Kingdom., Otieno MA; Planetary Health Eastern Africa Hub, Eldoret, Kenya.; Department of Environmental Biology and Health, University of Eldoret, Eldoret, Kenya., Siddiqa A; Fridays for Future MAPA.; Polluters Out and Fossil Free University.; Centre for Human Rights and Global Justice, New York University, New York, NY, United States of America., Singh A; Norwich Medical School, University of East Anglia, Norwich, United Kingdom.; Health for a Green New Deal, London, United Kingdom., Taomia BKE; Fridays for Future MAPA.; Saving Tuvalu, Funafuti, Tuvalu.
Publikováno v:
PLOS global public health [PLOS Glob Public Health] 2022 Nov 14; Vol. 2 (11), pp. e0001304. Date of Electronic Publication: 2022 Nov 14 (Print Publication: 2022).
Autor:
Otieno MA; Planetary Health Eastern Africa Hub, Eldoret, 30100, Kenya; Department of Environmental Biology and Health, University of Eldoret, Eldoret, Kenya. Electronic address: melvineanyango@gmail.com., Moonga G; Centre for International Health, Ludwig-Maximilians-Universität München, Munich, Germany., Nidens N; German Alliance on Climate Change and Health, Berlin, Germany; Faculty of Medicine, Leipzig University, Leipzig, Germany., Magero NV; Department of Economics and Social Sciences, Universität Potsdam, Potsdam, Germany., Jung L; German Alliance on Climate Change and Health, Berlin, Germany; Faculty of Medicine, Leipzig University, Leipzig, Germany; Department for Infectious Diseases and Tropical Medicine, Leipzig University, Leipzig, Germany.
Publikováno v:
The Lancet. Planetary health [Lancet Planet Health] 2022 Oct; Vol. 6 (10), pp. e775-e776.
Autor:
Baudy AR; Merck & Co., Inc., Kenilworth, NJ, USA. andreas.baudy@merck.com., Otieno MA; Janssen Pharmaceutical Research and Development, Spring House, PA, USA., Hewitt P; Merck KGaA, Darmstadt, Germany., Gan J; Bristol-Myers Squibb, New York City, NY, USA., Roth A; Roche Innovation Centre, Basel, Switzerland., Keller D; Sanofi, Bridgewater, NJ, USA., Sura R; AbbVie, Inc., Chicago, IL, USA., Van Vleet TR; AbbVie, Inc., Chicago, IL, USA., Proctor WR; Genentech, Inc., South San Francisco, CA, USA.
Publikováno v:
Lab on a chip [Lab Chip] 2020 Jan 21; Vol. 20 (2), pp. 215-225. Date of Electronic Publication: 2019 Dec 04.
Autor:
Jang KJ; Emulate Inc., 27 Drydock Avenue, Boston, MA 02210, USA., Otieno MA; Janssen Pharmaceutical Research and Development, Nonclinical Safety, 1400 Welsh and McKean Road, Spring House, PA 19477, USA. geraldine.hamilton@emulatebio.com motieno@its.jnj.com., Ronxhi J; Emulate Inc., 27 Drydock Avenue, Boston, MA 02210, USA., Lim HK; Janssen Pharmaceutical Research and Development, Drug Metabolism and Pharmacokinetics, 1400 Welsh and McKean Road, Spring House, PA 19477, USA., Ewart L; Clinical Pharmacology and Safety Sciences Department, Biopharmaceuticals Science Unit, AstraZeneca, Cambridge, CB4 0WG, UK., Kodella KR; Emulate Inc., 27 Drydock Avenue, Boston, MA 02210, USA., Petropolis DB; Emulate Inc., 27 Drydock Avenue, Boston, MA 02210, USA., Kulkarni G; Emulate Inc., 27 Drydock Avenue, Boston, MA 02210, USA., Rubins JE; Emulate Inc., 27 Drydock Avenue, Boston, MA 02210, USA., Conegliano D; Emulate Inc., 27 Drydock Avenue, Boston, MA 02210, USA., Nawroth J; Emulate Inc., 27 Drydock Avenue, Boston, MA 02210, USA., Simic D; Janssen Pharmaceutical Research and Development, Nonclinical Safety, 1400 Welsh and McKean Road, Spring House, PA 19477, USA., Lam W; Janssen Pharmaceutical Research and Development, Drug Metabolism and Pharmacokinetics, 1400 Welsh and McKean Road, Spring House, PA 19477, USA., Singer M; Janssen Pharmaceutical Research and Development, Nonclinical Safety, 1400 Welsh and McKean Road, Spring House, PA 19477, USA., Barale E; Janssen Pharmaceutical Research and Development, Nonclinical Safety, 1400 Welsh and McKean Road, Spring House, PA 19477, USA., Singh B; Janssen Pharmaceutical Research and Development, Nonclinical Safety, 1400 Welsh and McKean Road, Spring House, PA 19477, USA., Sonee M; Janssen Pharmaceutical Research and Development, Nonclinical Safety, 1400 Welsh and McKean Road, Spring House, PA 19477, USA., Streeter AJ; Janssen Pharmaceutical Research and Development, Nonclinical Safety, 1400 Welsh and McKean Road, Spring House, PA 19477, USA., Manthey C; Janssen Pharmaceutical Research and Development, IPD Biology, 1400 Welsh and McKean Road, Spring House, PA 19477, USA., Jones B; Clinical Pharmacology and Safety Sciences Department, Biopharmaceuticals Science Unit, AstraZeneca, Cambridge, CB4 0WG, UK., Srivastava A; Clinical Pharmacology and Safety Sciences Department, Biopharmaceuticals Science Unit, AstraZeneca, Cambridge, CB4 0WG, UK., Andersson LC; Clinical Pharmacology and Safety Sciences Department, Biopharmaceuticals Science Unit, AstraZeneca, Gothenburg SE-431 83, Sweden., Williams D; Clinical Pharmacology and Safety Sciences Department, Biopharmaceuticals Science Unit, AstraZeneca, Cambridge, CB4 0WG, UK., Park H; Emulate Inc., 27 Drydock Avenue, Boston, MA 02210, USA., Barrile R; Emulate Inc., 27 Drydock Avenue, Boston, MA 02210, USA., Sliz J; Emulate Inc., 27 Drydock Avenue, Boston, MA 02210, USA., Herland A; Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA 02115, USA., Haney S; Emulate Inc., 27 Drydock Avenue, Boston, MA 02210, USA., Karalis K; Emulate Inc., 27 Drydock Avenue, Boston, MA 02210, USA., Ingber DE; Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA 02115, USA.; Vascular Biology Program and Department of Surgery, Boston Children's Hospital and Harvard Medical School, Boston, MA 02115, USA.; Harvard John A. Paulson School of Engineering and Applied Sciences, Cambridge, MA 02139, USA., Hamilton GA; Emulate Inc., 27 Drydock Avenue, Boston, MA 02210, USA. geraldine.hamilton@emulatebio.com motieno@its.jnj.com.
Publikováno v:
Science translational medicine [Sci Transl Med] 2019 Nov 06; Vol. 11 (517).
Autor:
Holman NS; Institute for Drug Safety Sciences, University of North Carolina at Chapel Hill, Research Triangle Park, North Carolina 27709.; Curriculum in Toxicology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599., Church RJ; Institute for Drug Safety Sciences, University of North Carolina at Chapel Hill, Research Triangle Park, North Carolina 27709.; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, Chapel Hill, North Carolina 27599., Nautiyal M; Institute for Drug Safety Sciences, University of North Carolina at Chapel Hill, Research Triangle Park, North Carolina 27709., Rose KA; Institute for Drug Safety Sciences, University of North Carolina at Chapel Hill, Research Triangle Park, North Carolina 27709., Thacker SE; Institute for Drug Safety Sciences, University of North Carolina at Chapel Hill, Research Triangle Park, North Carolina 27709., Otieno MA; Preclinical Development and Safety, Janssen Research and Development, LLC, Spring House, Pennsylvania 19477., Wolf KK; Institute for Drug Safety Sciences, University of North Carolina at Chapel Hill, Research Triangle Park, North Carolina 27709., LeCluyse E; Institute for Drug Safety Sciences, University of North Carolina at Chapel Hill, Research Triangle Park, North Carolina 27709.; Curriculum in Toxicology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599., Watkins PB; Institute for Drug Safety Sciences, University of North Carolina at Chapel Hill, Research Triangle Park, North Carolina 27709.; Curriculum in Toxicology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599.; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, Chapel Hill, North Carolina 27599., Mosedale M; Institute for Drug Safety Sciences, University of North Carolina at Chapel Hill, Research Triangle Park, North Carolina 27709.; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, Chapel Hill, North Carolina 27599.
Publikováno v:
Toxicological sciences : an official journal of the Society of Toxicology [Toxicol Sci] 2019 Aug 01; Vol. 170 (2), pp. 499-508.
Autor:
Barrile R; Emulate Inc., Boston, Massachusetts, USA., van der Meer AD; Applied Stem Cell Technologies, University of Twente, Enschede, The Netherlands., Park H; Emulate Inc., Boston, Massachusetts, USA., Fraser JP; Emulate Inc., Boston, Massachusetts, USA., Simic D; Janssen Pharmaceutical Research and Development, Discovery & Manufacturing Sciences, Spring House, Pennsylvania, USA., Teng F; Janssen Pharmaceutical Research and Development, Discovery & Manufacturing Sciences, Spring House, Pennsylvania, USA., Conegliano D; Emulate Inc., Boston, Massachusetts, USA., Nguyen J; Emulate Inc., Boston, Massachusetts, USA., Jain A; Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, Massachusetts, USA., Zhou M; Janssen Pharmaceutical Research and Development, Discovery & Manufacturing Sciences, Spring House, Pennsylvania, USA., Karalis K; Emulate Inc., Boston, Massachusetts, USA., Ingber DE; Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, Massachusetts, USA., Hamilton GA; Emulate Inc., Boston, Massachusetts, USA., Otieno MA; Janssen Pharmaceutical Research and Development, Discovery & Manufacturing Sciences, Spring House, Pennsylvania, USA.
Publikováno v:
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2018 Dec; Vol. 104 (6), pp. 1240-1248. Date of Electronic Publication: 2018 Apr 30.
Autor:
Otieno MA; Preclinical Development and Safety, Janssen Pharmaceuticals, Spring House, Pennsylvania 19477., Snoeys J; Preclinical Development & Safety, Janssen Pharmaceutica NV, Beerse, Antwerpen BE 2340, Belgium., Lam W; Preclinical Development and Safety, Janssen Pharmaceuticals, Spring House, Pennsylvania 19477., Ghosh A; Preclinical Development and Safety, Janssen Pharmaceuticals, Spring House, Pennsylvania 19477., Player MR; Cardiovascular & Metabolism, Janssen Pharmaceuticals, Spring House, Pennsylvania 19477., Pocai A; Cardiovascular & Metabolism, Janssen Pharmaceuticals, Spring House, Pennsylvania 19477., Salter R; Preclinical Development and Safety, Janssen Pharmaceuticals, Spring House, Pennsylvania 19477., Simic D; Preclinical Development and Safety, Janssen Pharmaceuticals, Spring House, Pennsylvania 19477., Skaggs H; Preclinical Development and Safety, Janssen Pharmaceuticals, Spring House, Pennsylvania 19477., Singh B; Preclinical Development and Safety, Janssen Pharmaceuticals, Spring House, Pennsylvania 19477., Lim HK; Preclinical Development and Safety, Janssen Pharmaceuticals, Spring House, Pennsylvania 19477.
Publikováno v:
Toxicological sciences : an official journal of the Society of Toxicology [Toxicol Sci] 2018 Jun 01; Vol. 163 (2), pp. 374-384.
Autor:
Thacker SE; Division of Pharmacotherapy and Experimental Therapeutics and Institute for Drug Safety Sciences, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599., Nautiyal M; Division of Pharmacotherapy and Experimental Therapeutics and Institute for Drug Safety Sciences, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599., Otieno MA; Preclinical Development and Safety, Janssen Research and Development, LLC, Spring House, Pennsylvania 19477., Watkins PB; Division of Pharmacotherapy and Experimental Therapeutics and Institute for Drug Safety Sciences, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599., Mosedale M; Division of Pharmacotherapy and Experimental Therapeutics and Institute for Drug Safety Sciences, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599.
Publikováno v:
Toxicological sciences : an official journal of the Society of Toxicology [Toxicol Sci] 2018 May 01; Vol. 163 (1), pp. 92-100.
Autor:
Jain A; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, Massachusetts, USA.; Vascular Biology Program and Department of Surgery, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts, USA.; Division of Hemostasis and Thrombosis, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.; Department of Biomedical Engineering, Dwight Look College of Engineering, Texas A&M University, College Station, Texas, USA., Barrile R; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, Massachusetts, USA.; Cedars-Sinai Medical Center, Los Angeles, California, USA., van der Meer AD; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, Massachusetts, USA.; MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands., Mammoto A; Vascular Biology Program and Department of Surgery, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts, USA., Mammoto T; Vascular Biology Program and Department of Surgery, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts, USA., De Ceunynck K; Division of Hemostasis and Thrombosis, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA., Aisiku O; Division of Hemostasis and Thrombosis, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA., Otieno MA; Janssen Pharmaceutical Research and Development, Pre-Clinical Development and Safety, Spring House, Pennsylvania, USA., Louden CS; Janssen Pharmaceutical Research and Development, Pre-Clinical Development and Safety, Spring House, Pennsylvania, USA., Hamilton GA; Emulate Inc., Boston, Massachusetts, USA., Flaumenhaft R; Division of Hemostasis and Thrombosis, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA., Ingber DE; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, Massachusetts, USA.; Vascular Biology Program and Department of Surgery, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts, USA.; Harvard John A. Paulson School of Engineering and Applied Sciences, Cambridge, Massachusetts, USA.
Publikováno v:
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2018 Feb; Vol. 103 (2), pp. 332-340. Date of Electronic Publication: 2017 Jul 14.